This trial will assess the impact of immersive VR on pain and other patient-reported outcomes for people with digestive tract malignancies, as well as differences between skills-based VR therapy and distraction VR therapy.
1 Primary · 4 Secondary · Reporting Duration: At baseline, week of Day 30, and week of Day 60
360 Total Participants · 3 Treatment Groups
Primary Treatment: PICO G2 4k · Has Placebo Group · Phase 2
Age 18 - 99 · All Participants · 4 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: